Xencor Inc (XNCR)
18.34
+0.13
(+0.71%)
USD |
NASDAQ |
Apr 23, 16:00
18.38
+0.04
(+0.22%)
After-Hours: 20:00
Xencor Cash from Operations (Quarterly): 181.21M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 181.21M |
| September 30, 2023 | -27.28M |
| June 30, 2023 | -38.20M |
| March 31, 2023 | -30.61M |
| December 31, 2022 | -24.43M |
| September 30, 2022 | -1.168M |
| June 30, 2022 | 44.27M |
| March 31, 2022 | 5.815M |
| December 31, 2021 | 61.79M |
| September 30, 2021 | -39.02M |
| June 30, 2021 | -9.654M |
| March 31, 2021 | -29.97M |
| December 31, 2020 | 17.08M |
| September 30, 2020 | -3.866M |
| June 30, 2020 | -27.68M |
| March 31, 2020 | 9.46M |
| December 31, 2019 | -19.58M |
| September 30, 2019 | -6.477M |
| June 30, 2019 | 109.16M |
| March 31, 2019 | -18.73M |
| December 31, 2018 | -16.78M |
| September 30, 2018 | -10.31M |
| Date | Value |
|---|---|
| June 30, 2018 | -28.42M |
| March 31, 2018 | -24.24M |
| December 31, 2017 | -6.666M |
| September 30, 2017 | -3.509M |
| June 30, 2017 | -12.88M |
| March 31, 2017 | -10.55M |
| December 31, 2016 | -15.17M |
| September 30, 2016 | 134.07M |
| June 30, 2016 | -9.369M |
| March 31, 2016 | -14.30M |
| December 31, 2015 | -3.845M |
| September 30, 2015 | 39.52M |
| June 30, 2015 | -6.916M |
| March 31, 2015 | -2.093M |
| December 31, 2014 | -5.864M |
| September 30, 2014 | -4.72M |
| June 30, 2014 | -5.774M |
| March 31, 2014 | -4.993M |
| December 31, 2013 | -4.148M |
| September 30, 2013 | -4.112M |
| June 30, 2013 | 1.161M |
| March 31, 2013 | 1.646M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-39.02M
Minimum
Sep 2021
181.21M
Maximum
Dec 2023
8.992M
Average
-6.477M
Median
Sep 2019
Cash from Operations (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 32.86M |
| Karyopharm Therapeutics Inc | -18.58M |
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -203.13M |
| Cash from Financing (Quarterly) | 22.98M |
| Free Cash Flow | 63.86M |
| Free Cash Flow Per Share (Quarterly) | 2.950 |
| Free Cash Flow to Equity (Quarterly) | 158.53M |
| Free Cash Flow to Firm (Quarterly) | 179.50M |
| Free Cash Flow Yield | 5.77% |